| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084885 Modified transcription factor protein for use as tool in prevention and treatment of cell proliferative disorder |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084845 Immunoglobulin specific to hepatitis c viral envelope protein for use as tool prevention and treatment of viral diseases |
| 04/21/2005 | US20050084522 Cationic lipids for nuclei acid delivery |
| 04/21/2005 | US20050084513 Nanocoating for improving biocompatibility of medical implants |
| 04/21/2005 | US20050084497 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/21/2005 | US20050084480 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 04/21/2005 | US20050084456 Functionalized particles |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2542295A1 Method |
| 04/21/2005 | CA2542288A1 Chimeric promoter comprising hcmv major immediate early gene exons and a heterologous intron |
| 04/21/2005 | CA2541804A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2540775A1 Medical use of tbk-1 or of inhibitors thereof |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/20/2005 | EP1523992A1 Vaccine formulation against Gumboro disease |
| 04/20/2005 | EP1523577A2 Method for diagnosis of intestinal-type gastric tumors |
| 04/20/2005 | EP1523571A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 04/20/2005 | EP1523563A2 Modified adenoviral fiber with ablated to cellular receptors |
| 04/20/2005 | EP1453977A4 Molecular characteristics of non-small cell lung cancer |
| 04/20/2005 | EP1315807B1 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP1002120B1 Chimeric adenoviral vectors |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0787200B1 Improved adenovirus and methods of use thereof |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608135A Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/20/2005 | CN1607942A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607941A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607248A Multifunctional anticancer recombinant adenovirus |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 04/20/2005 | CN1197618C Mutant cholera holotoxin as an adjuvant |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |
| 04/19/2005 | US6881825 Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues |
| 04/19/2005 | US6881724 Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881556 Nucleotide sequences for use as tools in controlling gene expression in genetic engineering |
| 04/19/2005 | US6881555 AKT nucleic acids, polypeptides, and uses thereof |
| 04/19/2005 | US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 04/19/2005 | US6881402 Treating the cell with a Receptor Internalization and Degradation (RID) protein complex; antitumor agents; treating degenerative and immune disorders |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/19/2005 | CA2059137C Enhancement of musculature in animals |
| 04/14/2005 | WO2005033321A2 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | WO2005033314A2 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 04/14/2005 | WO2005033313A2 Intracelluar trapping of radionuclides by enzyme-mediated reduction |
| 04/14/2005 | WO2005033277A2 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase |
| 04/14/2005 | WO2005033269A2 Methods for inducing an immune response via oral administration of an adenovirus |
| 04/14/2005 | WO2005033266A2 Regulation of acheron expression |
| 04/14/2005 | WO2005033141A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | WO2005032597A1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | WO2005032596A1 Lentiviral apoe2 gene therapy |
| 04/14/2005 | WO2005032595A2 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 04/14/2005 | WO2005032574A1 Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway |
| 04/14/2005 | WO2005032561A1 INVENTION RELATING TO FUNCTION OF HIV-Vpr |
| 04/14/2005 | WO2005032512A2 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | WO2005032511A2 Nanoparticulate therapeutic biologically active agents |
| 04/14/2005 | WO2005032483A2 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | WO2005032476A2 Methods and compositions for cpg15-2 |
| 04/14/2005 | WO2005017170A3 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 04/14/2005 | WO2005000318A3 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/14/2005 | WO2004096257A8 Genetic modification of targeted regions of the cardiac conduction system |
| 04/14/2005 | WO2004092395A3 Modulators of telomere stability |
| 04/14/2005 | WO2004073624A3 Contraceptive methods and compositions related to proteasomal interference |
| 04/14/2005 | WO2004048533A3 Modulation of forkhead box c2 expression |
| 04/14/2005 | WO2004047767A3 Methods for identifying risk of breast cancer and treatments thereof |
| 04/14/2005 | WO2004044140A3 2’-substituted oligomeric compounds and compositions for use in gene modulations |
| 04/14/2005 | WO2004035676A3 Antisense modulation of notch (drosophila) homolog 4 expression |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | US20050080249 Genetic engineering; isolation polypeptides; heterogeneity amino acid sequences |
| 04/14/2005 | US20050080246 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 04/14/2005 | US20050080235 Ret ligand (RetL) for stimulating neural and renal growth |
| 04/14/2005 | US20050080234 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 04/14/2005 | US20050080231 Small peptides having apoptotic activities and their applications |
| 04/14/2005 | US20050080140 Administering peroxisome proliferator-activated receptor (PPAR) delta agonist; a prostacyclin synthase gene or a protein encoded by the gene; rheumatoid arthritis, osteoarthritis, Crohn's disease, Guillain-Barre syndrome, skin disorders, post by-pass surgery restenosis, transplantation rejection |
| 04/14/2005 | US20050080033 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | US20050080032 Modulating expression of an endogenous marine invertebrate gene or an endogenous gene in a pathogen that infects marine invertebrate by administering to invertebrate at least one dsRNA that comprises a sequence having substantial sequence homology to the endogenous pathogen gene |
| 04/14/2005 | US20050080030 Amplifying efficiency of transfection, providing aggregation, exposing to vector, monitoring efficiency of transfection |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080027 Methods enabling the production yield of viral vectors derived from piroviruses to be improved by using DNA methylation inhibitors and/or Herpes viruses in the production of viral vectors derived from parvoviruses; suitable for transferring genes into mammalian cells, in particular into human cells |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080013 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; multimeric Apo-A-1agonist; anticholesterol agents; hypercholesterolemia, septic shock |
| 04/14/2005 | US20050080002 Methods for the treatment and prevention of cancer |
| 04/14/2005 | US20050079616 Method of transducing ES cells |
| 04/14/2005 | US20050079615 Using plasmid to transfer and expression exogenous nucleotide sequences in cells or vascularized multi-cellular organism; heterologus gene expression; bioreactors; gene therapeutics; genetic vaccination |
| 04/14/2005 | US20050079613 Downregulation of cell surface glycoproteins by a family of human ubiquitin ligases |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079496 Using nuclear factor of activated t-cells (nf-at) transcription factor expression as diagnostic tool detection and treatment of cell proliferative disorders |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079211 Use of lipid conjugates in the treatment of diseases of the nervous system |
| 04/14/2005 | US20050079209 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 04/14/2005 | US20050079180 Manipulatin of oocyte maturation and male germ cell survival |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079163 Administering retroviral vector containing nucleic acid encoding a gene; antiproliferative agents; antitumor agents |
| 04/14/2005 | US20050079158 Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof |